Stock 1SXP SCHOTT PHARMA AG & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

All News SCHOTT Pharma AG & Co. KGaA Deutsche Boerse AG

Equities

1SXP

DE000A3ENQ51

Real-time Estimate Tradegate
Other stock markets
 02:45:25 2024-06-27 pm EDT 		5-day change 1st Jan Change
29.2 EUR +8.79% Intraday chart for SCHOTT Pharma AG & Co. KGaA +7.11% -17.10%
06:25pm German Stocks Reverse Two-Session Losing Streak DJ
12:06pm Schott Pharma recovers - confirmation of annual targets is well received DP

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
German Stocks Reverse Two-Session Losing Streak
DJ
Schott Pharma recovers - confirmation of annual targets is well received
DP
Schott Pharma expands production - focus on USA
DP
SCHOTT PHARMA : Jefferies sticks Neutral
ZD
SCHOTT Pharma : Presentation H1 2023/2024
PU
SCHOTT Pharma : Präsentation H1 2023/2024 (englisch)
PU
SCHOTT Pharma : Half-year report H1 2023/2024
PU
SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary
EQ
Expanding prefillable glass syringe output: SCHOTT Pharma opens state of the art production facility in Lukácsháza, Hungary
PU
Simplifying Subcutaneous Drug Administration, SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
AQ
SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
CI
SCHOTT PHARMA : Berenberg reiterates its Neutral rating
ZD
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Deutsche Bank Research lowers target for Schott Pharma - 'Buy'
DP
SCHOTT PHARMA : Receives a Buy rating from Deutsche Bank
ZD
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1SXP Stock
  4. 1SXP Stock
  5. News SCHOTT Pharma AG & Co. KGaA